NYSE
$50.39▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $10.39BShares out 2.100M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
3- 1d agoPre-market26.10.23 19:116-KKey event#●●●#●●●
QIAGEN N.V.Bullish
QIAGEN N.V. has entered into a definitive business combination agreement to be acquired by Crown NL Bidco B.V. for €46.50 per share in cash. The transaction has been unanimously approved by the boards of both companies and will be executed through a public tender offer.…more
$50.39+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 2d agoRegular26.10.22 23:23SC TO-COther
QIAGEN N.V.
EQT Private Equity has announced a voluntary all-cash public takeover offer to acquire all outstanding shares of QIAGEN N.V. at 46.50 euros per share. The transaction has received unanimous support from QIAGEN's boards and will result in the delisting of the company upon completion. The deal is expected to close in mid-2027, subject to a minimum 50% acceptance threshold and customary regulatory clearances.…more
$50.39+0.00%vs prev closeView filingShare - 3d agoPre-market26.10.22 07:11filedSC14D9COther
QIAGEN N.V.
QIAGEN has entered into a definitive agreement to be acquired by EQT Private Equity in an all-cash tender offer at 46.50 euros per share, valuing the company at approximately 10.8 billion euros. Upon completion of the transaction, expected in mid-2027, QIAGEN will be delisted and become a private company. The company reported preliminary Q3 2026 net sales of 548 million dollars and has suspended its full-year 2026 financial outlook.…more
$50.39+0.00%vs prev closeView filingShare
2 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoRegular26.10.23 02:04#●●●#●●●
Qiagen to be Acquired by EQT for $12.1 Billion
Life sciences firm Qiagen has agreed to be acquired by EQT AB in an all-cash deal valued at approximately $12.1 billion. The transaction offers a 40.3% premium to shareholders, though the company has suspended its 2026 financial outlook.…more
$50.39+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 3d agoAfter-hours26.10.22 06:50
●●●●●●●● ●●●●● ●●●●●●
QIAGEN reported preliminary Q3 net sales of $548 million and an adjusted EPS of $0.65. The company has suspended its full-year 2026 outlook due to the pending acquisition transaction with EQT Private Equity.…more
$50.39+0.00%vs prev closeShareBenzinga - 3d agoAfter-hours26.10.22 06:46
●●●●●●●● ●●●●● ●●●●●●
Qiagen has agreed to a public takeover offer from EQT Private Equity at €46.50 per share, representing a 40.3% premium. The transaction is expected to close in mid-2027, with full support from Qiagen's management boards.…more
$50.39+0.00%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report